Ca-AKG and grey hair: what the mouse study actually showed

Ca-AKG has not been shown to reverse grey hair in humans. The entire claim traces back to one secondary finding in the 2020 Shahmirzadi mouse study.

The finding itself is real: aged mice given Ca-AKG showed more melanocyte-containing hair follicles and visible fur repigmentation. What is not established is whether the same thing happens in human scalp hair.

What did the mouse study actually find?

The 2020 Cell Metabolism study was primarily a lifespan and healthspan experiment in middle-aged C57BL/6 mice [1].

Hair pigmentation was one component of the broader age-related phenotype analysis.

In treated mice, the proportion of hair follicles containing Dct-positive melanocytes increased from roughly 40% in controls to roughly 60% with Ca-AKG. Visible fur repigmentation was also reported.

That is more precise than saying “Ca-AKG reversed grey hair.” It increased a melanocyte-associated follicle measure and coat pigmentation in aged mice.

Was grey hair the primary endpoint?

No.

The study was designed around lifespan and a 31-parameter frailty index. Hair and coat characteristics were part of the broader aging phenotype, while the melanocyte analysis was a secondary tissue-level finding.

That does not make it invalid. It does mean the result deserves less weight than a dedicated, preregistered hair-pigmentation experiment.

Has the finding been replicated?

Not in the audited 63-paper Ca-AKG corpus.

The later NIA Interventions Testing Program studies focused on lifespan and did not provide an independent replication of the fur-repigmentation result [2] [3].

So the grey-hair claim remains dependent on one mouse program rather than a replicated body of pigmentation research.

Has Ca-AKG been tested for grey hair in people?

No published human Ca-AKG study in our audited corpus measured:

• grey-hair percentage;
• hair-shaft melanin;
• follicular melanocyte counts;
• melanocyte stem-cell function;
• or visible scalp-hair repigmentation.

The Rejuvant biological-age studies did not measure hair color, and ABLE is not a hair-pigmentation trial.

Do we know how AKG affected the mouse follicles?

Not well enough to claim a specific hair mechanism.

The same 2020 study reported lower inflammatory signaling, lower tissue p16/p21 expression and reduced SASP output in senescent fibroblasts. Those observations make senescence and inflammatory signaling plausible pieces of the wider aging phenotype [1].

But the study did not demonstrate a causal pathway such as “AKG lowered oxidative stress in melanocyte stem cells, therefore pigmentation returned.” That level of mechanistic specificity would be speculation.

Why mouse fur and human grey hair are not interchangeable

Both species rely on melanocyte biology, but hair-cycle structure, pigment maintenance, follicular stem-cell dynamics and coat/scalp physiology differ.

Human greying is also strongly influenced by genetics and age, and can be associated with several nutritional or medical conditions. A mouse coat-color result cannot be assigned a human effect size by analogy.

Does the lifespan replication problem affect the grey-hair finding?

Indirectly.

Two later multi-site NIA ITP studies did not reproduce a lifespan extension from AKG in genetically heterogeneous UM-HET3 mice [2] [3].

Those studies did not test pigmentation, so they do not disprove the fur finding. They do reinforce a broader lesson: effects observed in one mouse strain and laboratory program should not automatically be treated as universal properties of AKG.

Should you take Ca-AKG specifically for grey hair?

The evidence does not support buying Ca-AKG with an expectation of human hair repigmentation.

If someone chooses Ca-AKG for other reasons, hair color would be an unproven possible observation—not an evidence-based treatment target.

Persistent or unusually early greying can sometimes coexist with nutritional deficiencies, autoimmune conditions or other medical factors, although most greying is genetic and age-related. A supplement marketed from a mouse finding should not replace evaluation when there is a clinical reason to investigate.

Bottom line

The Ca-AKG grey-hair story is narrow but real: one 2020 mouse study found roughly more Dct-positive, melanocyte-containing hair follicles and visible fur repigmentation with Ca-AKG.

It remains a single, secondary, unreplicated animal finding with no human pigmentation data.

So the accurate claim is not “Ca-AKG reverses grey hair.” It is: Ca-AKG produced fur-repigmentation and melanocyte-associated changes in one aged-mouse study; whether this translates to human grey hair is unknown.

For the full study context, see the Shahmirzadi 2020 deep-dive.